Bruker (BRKR) to Release Earnings on Tuesday

Bruker (NASDAQ:BRKR) is expected to be posting its quarterly earnings results before the market opens on Tuesday, February 11th. Analysts expect Bruker to post earnings of $0.75 per share and revenue of $965.61 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Bruker Stock Performance

BRKR opened at $55.59 on Monday. The company has a current ratio of 1.66, a quick ratio of 0.73 and a debt-to-equity ratio of 1.24. Bruker has a 12-month low of $48.07 and a 12-month high of $94.86. The firm has a 50 day moving average of $58.32 and a two-hundred day moving average of $61.04. The firm has a market capitalization of $8.43 billion, a PE ratio of 26.73, a P/E/G ratio of 3.81 and a beta of 1.16.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were given a dividend of $0.05 per share. The ex-dividend date was Monday, December 2nd. This represents a $0.20 dividend on an annualized basis and a yield of 0.36%. Bruker’s dividend payout ratio is presently 9.62%.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. The Goldman Sachs Group upgraded Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price target for the company in a research report on Thursday, December 5th. TD Cowen decreased their target price on shares of Bruker from $72.00 to $70.00 and set a “hold” rating for the company in a research note on Wednesday, November 6th. UBS Group started coverage on shares of Bruker in a report on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 price objective for the company. Guggenheim reissued a “buy” rating on shares of Bruker in a research note on Friday, January 17th. Finally, Bank of America lifted their price target on Bruker from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Six research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $74.45.

Insider Activity at Bruker

In other news, CEO Frank H. Laukien bought 100,000 shares of the company’s stock in a transaction on Monday, November 18th. The stock was bought at an average cost of $50.14 per share, with a total value of $5,014,000.00. Following the transaction, the chief executive officer now directly owns 38,439,563 shares in the company, valued at $1,927,359,688.82. The trade was a 0.26 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 28.30% of the stock is owned by insiders.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.